521 related articles for article (PubMed ID: 26541778)
21. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.
Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W
Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180
[TBL] [Abstract][Full Text] [Related]
22. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.
Hong H; Yan Y; Shi S; Graves SA; Krasteva LK; Nickles RJ; Yang M; Cai W
Mol Pharm; 2015 Feb; 12(2):403-10. PubMed ID: 25581441
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Detection of HER2 Expression in Gastric Cancer by
Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
[TBL] [Abstract][Full Text] [Related]
24. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
[TBL] [Abstract][Full Text] [Related]
25. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
[TBL] [Abstract][Full Text] [Related]
26. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
[TBL] [Abstract][Full Text] [Related]
27. Targeting Phosphatidylserine with a
Perreault A; Richter S; Bergman C; Wuest M; Wuest F
Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
[TBL] [Abstract][Full Text] [Related]
28. Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.
Lee JH; Kim H; Yao Z; Lee SJ; Szajek LP; Grasso L; Pastan I; Paik CH
Nucl Med Biol; 2015 Nov; 42(11):880-6. PubMed ID: 26307499
[TBL] [Abstract][Full Text] [Related]
29. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
30. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive Evaluation of CD20 Expression Using
Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
[TBL] [Abstract][Full Text] [Related]
33. Development of
Woo SK; Jang SJ; Seo MJ; Park JH; Kim BS; Kim EJ; Lee YJ; Lee TS; An GI; Song IH; Seo Y; Kim KI; Kang JH
J Nucl Med; 2019 Jan; 60(1):26-33. PubMed ID: 29777007
[TBL] [Abstract][Full Text] [Related]
34. Quantitative PET imaging of VEGF receptor expression.
Chen K; Cai W; Li ZB; Wang H; Chen X
Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964
[TBL] [Abstract][Full Text] [Related]
35. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
[TBL] [Abstract][Full Text] [Related]
36. Monitoring CD8a
Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
[TBL] [Abstract][Full Text] [Related]
37. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.
Zhang Y; Hong H; Engle JW; Yang Y; Barnhart TE; Cai W
Am J Nucl Med Mol Imaging; 2012 Jan; 2(1):1-13. PubMed ID: 22229128
[TBL] [Abstract][Full Text] [Related]
38. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
[TBL] [Abstract][Full Text] [Related]
39. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
[TBL] [Abstract][Full Text] [Related]
40. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
